Table 1.
Age of men with and without ED diagnosis or PDE5I prescription in MarketScan claims database and Humedica EHR database
| With ED Diagnosis or Treatment | Without ED Diagnosis or Treatment | |
|---|---|---|
| MarketScan Claims Database | ||
| Number of men (% of total) | ||
| Total | 1,108,842 (100) | 18,725,097 (100) |
| ED diagnosis only | 404,575 (36.5) | – |
| PDE5I prescription only | 464,039 (41.8) | – |
| ED diagnosis and PDE5I prescription | 240,228 (21.7) | – |
| Mean (SD) age, years | 55.2 (11.2) | 43.7 (16.5) |
| Range | 18–100 | 18–120 |
| Age group, years, n (% of total) | ||
| 18–29 | 19,180 (1.7) | 4,563,501 (24.4) |
| 30–39 | 73,731 (6.6) | 3,454,937 (18.5) |
| 40–49 | 223,153 (20.1) | 3,723,583 (19.9) |
| 50–59 | 399,669 (36.0) | 3,609,524 (19.3) |
| 60–69 | 289,919 (26.1) | 2,221,472 (11.9) |
| 70–79 | 83,290 (7.5) | 671,891 (3.6) |
| 80–89 | 19,127 (1.7) | 396,345 (2.1) |
| ≥90 | 773 (0.1) | 83,844 (0.4) |
| Humedica EHR Database | ||
| Number of men (% of total) | ||
| Total | 364,723 (100) | 4,927,647 |
| ED diagnosis only | 107,529 (29.5) | – |
| PDE5I prescription only | 100,031 (27.4) | – |
| ED diagnosis and PDE5I prescription | 157,163 (43.1) | – |
| Mean (SD) age, years | 58.1 (11.9) | 49.9 (19.0) |
| Range | 18–84 | 18–84 |
| Age group, years, n (% of subgroup) | ||
| 18–29 | 5,212 (1.4) | 919,114 (18.7) |
| 30–39 | 18,591 (5.1) | 718,919 (14.6) |
| 40–49 | 59,392 (16.3) | 782,266 (15.9) |
| 50–59 | 111,653 (30.6) | 880,516 (17.9) |
| 60–69 | 106,105 (29.1) | 719,791 (14.6) |
| 70–79 | 54,226 (14.9) | 527,542 (10.7) |
| 80–89 | 9,544 (2.6) | 379,499 (7.7) |
ED=erectile dysfunction; EHR=electronic health records; PDE5I=phosphodiesterase type 5 inhibitor.